Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mayers

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 1992
Hospital-acquired wound mucormycosisS F Paparello, R L Parry, D C MacGillivray, et al.
Journal of Clinical Pharmacology|April 28, 2009
Population pharmacokinetics of telbivudine and determination of dose adjustment for patients with renal impairmentXiao-Jian Zhou, June Ke, William M Sallas, et al.
Archives of Virology|July 12, 2002
Genetic diversity and response to IFN of the NS3 protease gene from clinical strains of the hepatitis C virusC A Holland-Staley, L C Kovari, E M Golenberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1982
Hapten-specific B cell repertoire probed by hybridoma technology: selection and characterization of representative clonotypes from the antibody-forming cell poolA G Bloor, Y Jou, C Hoeplinger, et al.
Journal of the American College of Surgeons|May 3, 2001
Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trialM Moore, W E Burak, E Nelson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2003
A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patientsJerry O Stern, Patrick A Robinson, James Love, et al.
Annals of Clinical and Laboratory Science|April 21, 2001
Fibrin sealant: clinical use and the development of the University of Virginia Tissue Adhesive CenterP D Mintz, L Mayers, N Avery, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 21, 2004
A 14-day dose-response study of the efficacy, safety, and pharmacokinetics of the nonpeptidic protease inhibitor tipranavir in treatment-naive HIV-1-infected patientsScott McCallister, Hernan Valdez, Kevin Curry, et al.
JAMA|April 17, 1981
Rapidly expanding pulmonary nodule caused by Pittsburgh pneumonia agentA R Ellis, D L Mayers, W J Martone, et al.
Journal of Clinical Microbiology|September 1, 1994
Standardized microtiter assay for determination of syncytium-inducing phenotypes of clinical human immunodeficiency virus type 1 isolatesA J Japour, S A Fiscus, J M Arduino, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 1992
Hospital-acquired wound mucormycosisS F Paparello, R L Parry, D C MacGillivray, et al.
Journal of Clinical Pharmacology|April 28, 2009
Population pharmacokinetics of telbivudine and determination of dose adjustment for patients with renal impairmentXiao-Jian Zhou, June Ke, William M Sallas, et al.
Archives of Virology|July 12, 2002
Genetic diversity and response to IFN of the NS3 protease gene from clinical strains of the hepatitis C virusC A Holland-Staley, L C Kovari, E M Golenberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1982
Hapten-specific B cell repertoire probed by hybridoma technology: selection and characterization of representative clonotypes from the antibody-forming cell poolA G Bloor, Y Jou, C Hoeplinger, et al.
Journal of the American College of Surgeons|May 3, 2001
Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trialM Moore, W E Burak, E Nelson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2003
A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patientsJerry O Stern, Patrick A Robinson, James Love, et al.
Annals of Clinical and Laboratory Science|April 21, 2001
Fibrin sealant: clinical use and the development of the University of Virginia Tissue Adhesive CenterP D Mintz, L Mayers, N Avery, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 21, 2004
A 14-day dose-response study of the efficacy, safety, and pharmacokinetics of the nonpeptidic protease inhibitor tipranavir in treatment-naive HIV-1-infected patientsScott McCallister, Hernan Valdez, Kevin Curry, et al.
JAMA|April 17, 1981
Rapidly expanding pulmonary nodule caused by Pittsburgh pneumonia agentA R Ellis, D L Mayers, W J Martone, et al.
Journal of Clinical Microbiology|September 1, 1994
Standardized microtiter assay for determination of syncytium-inducing phenotypes of clinical human immunodeficiency virus type 1 isolatesA J Japour, S A Fiscus, J M Arduino, et al.
Pageof 10